Precigen Ownership | Who Owns Precigen?
Precigen Ownership Summary
Precigen is owned by 45.27% institutional investors, 12.67% insiders, and 42.06% retail investors. Patient capital management is the largest institutional shareholder, holding 6.08% of PGEN shares. Patient Opportunity C is the top mutual fund, with 3.62% of its assets in Precigen shares.
PGEN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Precigen | 45.27% | 12.67% | 42.06% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Patient capital management | 19.04M | 6.08% | $108.51M |
| Blackrock funding, inc. /de | 17.15M | 5.48% | $97.74M |
| Blackrock | 10.25M | 4.11% | $16.19M |
| State street | 12.00M | 3.83% | $68.41M |
| Vanguard group | 10.48M | 3.54% | $43.80M |
| Diametric capital, lp | 9.27M | 2.96% | $52.84M |
| Vanguard capital management | 7.91M | 2.53% | $45.07M |
| Tang capital management | 6.42M | 2.05% | $36.58M |
| Boxer capital management | 5.15M | 1.65% | $29.36M |
| Geode capital management | 5.02M | 1.60% | $28.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Iridian asset management llc/ct | 4.03M | 7.90% | $22.98M |
| Diametric capital, lp | 9.27M | 5.57% | $52.84M |
| Patient capital management | 19.04M | 3.56% | $108.51M |
| Boxer capital management | 5.15M | 2.21% | $29.36M |
| Tang capital management | 6.42M | 1.66% | $36.58M |
| Emfo | 519.48K | 0.73% | $820.77K |
| Persistent asset partners | 355.77K | 0.61% | $2.03M |
| Lansing street advisors | 495.42K | 0.60% | $2.82M |
| Essex investment management | 706.29K | 0.53% | $4.03M |
| Lexaurum advisors | 638.41K | 0.42% | $3.64M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Diametric capital, lp | 9.27M | 5.57% | 2.47M |
| First trust advisors lp | 2.01M | 0.01% | 2.01M |
| Blackrock funding, inc. /de | 17.15M | 0.00% | 1.92M |
| Boxer capital management | 5.15M | 2.21% | 1.65M |
| Vanguard group | 10.48M | 0.00% | 1.54M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 1.27M | 0.01% | -5.38M |
| Citadel advisors | 820.39K | 0.00% | -1.88M |
| Jane street group | - | - | -1.82M |
| Franklin resources | 1.03M | 0.00% | -1.61M |
| Parkman healthcare partners | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| First trust advisors lp | 2.01M | 0.01% | 2.01M | $11.48M |
| Sixth street partners management company | 1.52M | 0.00% | 1.52M | $8.64M |
| Essex investment management | 706.29K | 0.53% | 706.29K | $4.03M |
| Renaissance | 605.30K | 0.00% | 605.30K | $3.45M |
| Los angeles capital management | 381.62K | 0.01% | 381.62K | $2.18M |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| Capital performance advisors llp | -2.00 |
| Pnc financial services group | -19.00 |
| Financial consulate | -70.00 |
| Total investment management | -86.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 222 | 4.23% | 141,688,293 | 6.03% | 45 | 2.48% | 122 | 7.02% | 47 | - |
| Mar 31, 2026 | 118 | -35.87% | 44,277,448 | -67.44% | 14 | 0.67% | 61 | -45.05% | 23 | -36.11% |
| Dec 31, 2025 | 113 | -35.80% | 67,502,683 | -39.35% | 22 | 1.62% | 69 | -26.60% | 19 | -52.50% |
| Sep 30, 2025 | 170 | 15.65% | 111,283,863 | 41.15% | 37 | 5.31% | 91 | 42.19% | 38 | 15.15% |
| Jun 30, 2025 | 148 | 4.23% | 81,957,215 | 2.59% | 27 | 3.30% | 64 | 6.67% | 34 | -17.07% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Patient Opportunity C | 12.90M | 3.62% | - |
| Patient Opportunity Equity | 12.90M | 3.60% | - |
| State Street® SPDR® S&P® Biotech ETF | 6.98M | 1.95% | 16.02K |
| Vanguard US Total Market Shares ETF | 5.45M | 1.85% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.69M | 1.60% | 688.70K |
| Vanguard Morn Total Stk Mkt Idx Investor | 5.69M | 1.60% | 688.70K |
| Vanguard MStar Total Stk Mkt Idx Invest | 5.69M | 1.59% | - |
| iShares Russell 2000 ETF | 4.89M | 1.37% | -86.88K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.05M | 0.57% | 3.66K |
| Fidelity Small Cap Index | 1.81M | 0.51% | 23.69K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 26, 2026 | KINDLER JEFFREY B | - | Sell | $1.38M |
| Aug 21, 2026 | AGEE NANCY H | - | Buy | $24.66K |
| Aug 21, 2026 | Shah Rutul R | Chief Operating Officer | Sell | $259.94K |
| Aug 25, 2026 | Shah Rutul R | Chief Operating Officer | Sell | $115.06K |
| Aug 25, 2026 | Tennant Phil | Chief Commercial Officer | Sell | $593.75K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 1 | 8 |
| 2026 Q2 | - | 8 |
| 2026 Q1 | - | 11 |
| 2025 Q4 | - | 15 |
| 2025 Q3 | 7 | 5 |
PGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools